Furosemide Oral Solution
Hikma Pharmaceuticals USA, Inc. · Available · Reason: Shortage of an inactive ingredient component
Open FDA's page for this record- Update type
- Revised
- Initial posting date
- 03/31/2026
- Package NDC
- 0054-3298-63
- Generic name
- Furosemide Oral Solution
- Contact info
- 800-631-2174
- Availability
- Available
- Update date
- 09/18/2026
- Dosage form
- Oral Solution
- Presentation
- Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63)
- Company name
- Hikma Pharmaceuticals USA, Inc.
- Shortage reason
- Shortage of an inactive ingredient component
- Status
- Current
- Therapeutic category
- Cardiovascular
- Harmonized identifiers (openFDA)
- Application number
- ANDA070433
- Brand name
- FUROSEMIDE
- Generic name
- FUROSEMIDE
- Manufacturer name
- Hikma Pharmaceuticals USA Inc.
- Product NDC
- 0054-3298, 0054-4297, 0054-8297, 0054-4299, 0054-8299, 0054-4301, 0054-8301, 0054-3294
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- FUROSEMIDE
- RxCUI
- 197730, 197731, 197732, 310429, 313988
- SPL ID
- bc62ddda-7639-4090-99f0-7dd4d13518f3
- SPL set ID
- 9e493331-dddd-496e-abf8-61747fb67aba
- Package NDC
- 0054-4297-31, 0054-4297-25, 0054-8297-25, 0054-4299-31, 0054-4299-25, 0054-8299-25, 0054-4301-29, 0054-4301-25, 0054-8301-25, 0054-3298-63, 0054-3294-50, 0054-3294-46
- Nui
- N0000175366, N0000175590
- Pharm class pe
- Increased Diuresis at Loop of Henle [PE]
- Pharm class epc
- Loop Diuretic [EPC]
- UNII
- 7LXU5N7ZO5